ARCHIVES

In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires

This article is from The Cancer Letter archive.

Vol. 20 No. 34 | September 9, 1994

Download PDF Visit The Full Archive

Related Articles

Combined analysis moves Herceptin to adjuvant setting in breast cancer.

May 27, 2005

In Brief: Beahrs, Murphy, Quan Honored By SSO; AACR Award Mulligan, Wiggler, Sporn, Witte

March 29, 1991

Wyden, Schroeder Bill Would Require NIH To Test RU 486

October 23, 1992

CCIRC Starts Preparing For Clinical Research Review; To Include Group Achievements, Problems

March 3, 1978

NCCS Selects New President

October 9, 2009

Lines Drawn Over HHS Appropriations.

October 5, 2007